U.S. Packaging Stock News

NYSE:XYL
NYSE:XYLMachinery

How Xylem’s Buybacks, Shelf Filing and Trimmed 2026 Outlook Will Impact Xylem (XYL) Investors

Xylem Inc. recently filed an omnibus shelf registration covering a wide range of securities and, in the latest quarter, reported higher year-over-year revenue and earnings alongside a US$1.05 billion completed share repurchase, while also recording US$4 million of intangible asset impairments. At the same time, management slightly reduced its full-year 2026 revenue growth outlook even as it reiterated plans to deploy about US$1 billion annually toward acquisitions, highlighting an active...
NYSE:PRSU
NYSE:PRSUHospitality

Pursuit Attractions And Hospitality (PRSU) Rebrands Following A Strong Run, Is It Still Cheap?

Pursuit Attractions and Hospitality (PRSU) recently completed its rebranding from Viad Corp, bringing its portfolio of travel experiences under a single identity. This shift now anchors investor attention on the stock’s recent performance and fundamentals. See our latest analysis for Pursuit Attractions and Hospitality. The recent rebrand has arrived after a strong run, with Pursuit Attractions and Hospitality recording a 53.55% year to date share price return and a 77.02% total shareholder...
NasdaqGS:AMAT
NasdaqGS:AMATSemiconductor

Applied Materials (AMAT) Stock Looks Fairly Valued Despite China Risks

Applied Materials stock has delivered very strong gains over the last few years, yet the latest valuation checks suggest it no longer looks like an obvious bargain, especially with sector volatility back in focus after recent headlines on interest rates and Chinese competition. Applied Materials has returned 291.5% over the past 5 years, which puts extra pressure on today’s buyers to justify the current price with future cash flows. Expectations around continued demand for semiconductor...
NYSE:BMY
NYSE:BMYPharmaceuticals

Bristol Myers Squibb (BMY) After AstraZeneca Deal Talk Looks Fully Valued

Bristol-Myers Squibb (BMY) is back in focus after reports of early stage merger talks with AstraZeneca that could create a combined group valued near US$400b based on current market capitalizations. See our latest analysis for Bristol-Myers Squibb. The merger speculation comes on top of a strong run for Bristol-Myers Squibb, with the stock showing a 12.63% 1 month share price return and a 22.47% year to date share price return. The 1 year total shareholder return of 49.65% points to momentum...
NYSE:JAN
NYSE:JANHealth Care REITs

Charter Hall Stock And 2 More Shares Linked To Retiree Spending

Retiree spending sits at the heart of many consumer and healthcare trends, and a proposed change to Social Security cost of living adjustments could reshape that flow of money. If benefits eventually track the higher of CPI-W or CPI-E from 2027 to 2036, some companies exposed to retiree demand may see a different backdrop for revenue, dividends, and capital allocation. This article walks through three stocks from the Retiree Consumer Spending Beneficiaries screener that appear closely tied to...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

Where Does Meta Platforms (META) Valuation Sit As AI Spending Shapes Its Latest Results?

Meta Platforms (META) is back in focus after its latest round of earnings and guidance, which paired strong revenue figures with higher AI infrastructure spending that has weighed on recent share price performance. See our latest analysis for Meta Platforms. Meta Platforms’ latest earnings and guidance have kept the focus on heavy AI infrastructure investment, and the stock’s recent moves reflect that mixed sentiment. Despite a strong 1-day share price return of 6.02%, the year to date share...
NYSE:V
NYSE:VDiversified Financial

Visa (V) Is Buying BioCatch For $2.4 Billion To Push Deeper Into AI Fraud Tools

Visa agreed to acquire AI-based fraud intelligence firm BioCatch for $2.4b. The deal is aimed at expanding Visa's real-time fraud detection and cybersecurity tools. BioCatch focuses on behavioral analytics to help identify and prevent digital scams. Visa, traded as NYSE:V, is moving further into AI-driven security with the planned $2.4b purchase of BioCatch. The company recently closed at $365.67, with the stock up 56.3% over the past 3 years and 59.4% over the past 5 years. This highlights...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Why Corcept Therapeutics (CORT) Is Up 19.8% After Boosting 2026 Revenue Guidance And Earnings

In late July 2026, Corcept Therapeutics reported second-quarter net income of US$42.99 million, up from US$35.15 million a year earlier, with diluted earnings per share from continuing operations rising to US$0.36 from US$0.29. Alongside these stronger quarterly profits, the company raised its full-year 2026 revenue guidance to between US$1.1 billion and US$1.2 billion, signalling management’s confidence in its business momentum. We’ll now examine how Corcept’s upgraded 2026 revenue guidance...
NasdaqGM:HLMN
NasdaqGM:HLMNMachinery

Hillman Solutions (HLMN) Could Be 17% Below Fair Value On Raised Guidance And Q2 Beat

Why Hillman Solutions Stock Is Back In Focus After Q2 Earnings Hillman Solutions (HLMN) is back on investor watchlists after Q2 2026 earnings, where revenue and profit topped expectations and management raised full year guidance alongside announcing the Kanebridge Corporation acquisition. See our latest analysis for Hillman Solutions. The Q2 surprise has given Hillman Solutions fresh momentum, with a 1 day share price return of 5.59% lifting recent gains. However, the year to date share price...
NYSE:JEF
NYSE:JEFCapital Markets

How Investors Are Reacting To Jefferies Financial Group (JEF) New Long-Dated Fixed-Income Offerings Amid Asset Scrutiny

In late July 2026, Jefferies Financial Group announced and completed several fixed-income offerings, issuing senior unsecured, callable global medium-term notes with fixed coupons ranging from 5.55% to 7.00% and maturities between 2031 and 2056. These bond deals come as Jefferies reports record investment banking revenues and strong equities trading, while also contending with higher expenses and scrutiny over asset management exposures such as the Point Bonita Capital fund and links to...
NYSE:MAS
NYSE:MASBuilding

Masco (MAS) After Earnings And Buybacks, Does The Undervalued Case Still Hold?

Masco (MAS) is back in focus after reporting second quarter results with higher net income and earnings per share, issuing fresh full year earnings guidance, and completing a sizable share repurchase program. See our latest analysis for Masco. Masco's latest earnings update arrived after a choppy stretch for the stock, with a 30 day share price return of down 9.71% and a 7 day return of down 8.43%. However, the year to date share price return of 15.91% and 1 year total shareholder return of...
NYSE:ALSN
NYSE:ALSNMachinery

Allison Transmission Holdings (ALSN) Lifts Guidance, Is The Stock Still Undervalued?

Allison Transmission Holdings (ALSN) just released Q2 2026 results, reporting sales of US$1.57b and net income of US$181 million, along with a higher full year net sales and earnings outlook. See our latest analysis for Allison Transmission Holdings. Allison Transmission Holdings' share price has moved higher year to date, with a 17.56% gain, while the 36.13% 1-year total shareholder return and 226.42% 5-year total shareholder return suggest longer term momentum has been strong. The recent...
NasdaqGS:SKWD
NasdaqGS:SKWDInsurance

The Bull Case For Skyward Specialty Insurance Group (SKWD) Could Change Following Earnings Outperformance And Steady Forecasts

Skyward Specialty Insurance Group recently drew attention ahead of its latest earnings release, after previously reporting revenue that exceeded analyst expectations and showed strong year-on-year growth. Analysts have largely maintained their forecasts despite this outperformance, suggesting the market is closely watching whether the company can sustain its execution as it reports new results. We’ll now examine how Skyward’s recent earnings outperformance and steady analyst expectations may...
NasdaqGS:CBRL
NasdaqGS:CBRLHospitality

Cracker Barrel Old Country Store (CBRL) Could Be 46% Above Fair Value Following CEO Change

Cracker Barrel Old Country Store (CBRL) is entering a new chapter after announcing that veteran restaurant executive David Deno will become CEO and join the Board, succeeding Julie Masino in August 2026. See our latest analysis for Cracker Barrel Old Country Store. The CEO transition appears to be landing against strong recent momentum in Cracker Barrel Old Country Store’s share price, with a 90 day share price return of 88.09% and a year to date share price return of 115.20%, even as the 5...
NasdaqGS:ERII
NasdaqGS:ERIIMachinery

Exploring Undervalued Small Caps With Insider Action In August 2026

Over the last 7 days, the United States market has risen 2.4%, contributing to a robust 20% increase over the past year, with earnings expected to grow by 17% annually. In this dynamic environment, identifying small-cap stocks that are potentially undervalued and exhibit insider action can offer unique opportunities for investors seeking to capitalize on growth potential.
NYSE:GLW
NYSE:GLWElectronic

Dell Technologies And 2 More Stocks That Investors May Be Undervaluing

The United States market has shown robust performance, climbing 2.4% in the last week and up 20% over the past year, with earnings forecasted to grow by 17% annually. In such a thriving environment, identifying undervalued stocks like Dell Technologies can offer investors opportunities to capitalize on potential growth that may not yet be fully recognized by the market.
NasdaqGS:SMCI
NasdaqGS:SMCITech

3 Growth Companies With Insider Ownership Up To 34%

The market has shown positive momentum, rising 2.4% over the last week and up 20% over the past year, with earnings projected to grow by 17% annually. In this environment, growth companies with significant insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business.
NasdaqCM:MVST
NasdaqCM:MVSTMachinery

Alto Ingredients And 2 Other Promising Penny Stocks

The market has climbed 2.4% in the last 7 days and 20% over the past year, with earnings forecast to grow by 17% annually. Though the term 'penny stock' might sound like a relic of past trading days, these investments still present opportunities for growth at lower price points when backed by strong financials. In this article, we explore three penny stocks that combine balance sheet strength with potential for outsized gains, offering investors a chance to uncover hidden value in quality...